Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions

Clinical Biochemistry

Volumn 38, Issue 11, 2005, Pages 1031-1033

  Porcel, José Manuel ^a   Salud, Antonieta ^a   Vives, Manuel ^b   Esquerda, Aureli ^a   Rodríguez Panadero, Francisco ^c  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b Division of Internal Medicine   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

CA 15 3; CEA; HER 2 neu; Pleural effusion; Tumor marker

Indexed keywords

CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; ADENOCARCINOMA; BREAST TUMOR; CHEMISTRY; LABORATORY DIAGNOSIS; LUNG TUMOR; MIDDLE AGED; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FALSE NEGATIVE REACTIONS; HUMANS; LIKELIHOOD FUNCTIONS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; RECEPTOR, ERBB-2; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 27744534777     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2005.05.001     Document Type: Article

References (5)

1. R.W. Light Tumor markers in undiagnosed pleural effusions Chest 126 2004 1721 1722
2. T.L. Hung, F.F. Chen, and J.M. Liu Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis Clin. Cancer Res. 9 2003 2605 2612
3. M. Vives, J.M. Porcel, and M.C. Vicente de Vera A study of Light's criteria and possible modifications for distinguishing exudative from transudative pleural effusions Chest 109 1996 1503 1507
4. W.P. Carney, R. Neumann, A. Lipton, K. Leitzel, S. Ali, and C.P. Price Potential clinical utility of serum HER-2/neu oncoprotein concentrations in patients with breast cancer Clin. Chem. 49 2003 1579 1598
5. J.M. Porcel, M. Vives, A. Esquerda, A. Salud, B. Pérez, and F. Rodríguez-Panadero Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions Chest 126 2004 1757 1763